In this observational study, the use of nPOS was associated with improvements in key TMJ-OA symptoms and condylar morphology, especially during the early to mid-treatment phase (3-12 months). These findings warrant validation in randomized controlled trials before clinical adoption. Furthermore, long-term effects require further investigation.
Liu et al. (Mon,) studied this question.